DE SALVO, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.873
AS - Asia 1.447
EU - Europa 528
SA - Sud America 202
AF - Africa 199
Continente sconosciuto - Info sul continente non disponibili 55
OC - Oceania 11
Totale 5.315
Nazione #
US - Stati Uniti d'America 2.761
SG - Singapore 441
HK - Hong Kong 244
CN - Cina 205
VN - Vietnam 180
BR - Brasile 137
IT - Italia 126
BD - Bangladesh 96
DE - Germania 59
FR - Francia 46
IN - India 44
GB - Regno Unito 33
FI - Finlandia 29
JP - Giappone 28
CA - Canada 27
SE - Svezia 25
TR - Turchia 25
BJ - Benin 24
RU - Federazione Russa 23
PL - Polonia 21
IQ - Iraq 20
NL - Olanda 16
AR - Argentina 14
ID - Indonesia 14
ZA - Sudafrica 13
ES - Italia 12
KE - Kenya 12
MX - Messico 12
PH - Filippine 12
AT - Austria 11
JM - Giamaica 11
KR - Corea 10
MN - Mongolia 9
PK - Pakistan 9
HR - Croazia 8
LY - Libia 8
PY - Paraguay 8
RO - Romania 8
SA - Arabia Saudita 8
TN - Tunisia 8
UA - Ucraina 8
UZ - Uzbekistan 8
BB - Barbados 7
BE - Belgio 7
BG - Bulgaria 7
BZ - Belize 7
CI - Costa d'Avorio 7
CO - Colombia 7
CR - Costa Rica 7
DK - Danimarca 7
EC - Ecuador 7
JO - Giordania 7
LB - Libano 7
SN - Senegal 7
TH - Thailandia 7
VE - Venezuela 7
AO - Angola 6
CZ - Repubblica Ceca 6
EE - Estonia 6
IL - Israele 6
ME - Montenegro 6
MR - Mauritania 6
MY - Malesia 6
PT - Portogallo 6
UY - Uruguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
YE - Yemen 6
ZM - Zambia 6
AM - Armenia 5
AZ - Azerbaigian 5
CG - Congo 5
CH - Svizzera 5
CL - Cile 5
CM - Camerun 5
CU - Cuba 5
IE - Irlanda 5
KG - Kirghizistan 5
KZ - Kazakistan 5
MD - Moldavia 5
NE - Niger 5
NI - Nicaragua 5
NP - Nepal 5
PR - Porto Rico 5
RE - Reunion 5
SI - Slovenia 5
TZ - Tanzania 5
ZW - Zimbabwe 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
CD - Congo 4
CW - ???statistics.table.value.countryCode.CW??? 4
GA - Gabon 4
HT - Haiti 4
HU - Ungheria 4
IS - Islanda 4
MA - Marocco 4
MW - Malawi 4
NO - Norvegia 4
PS - Palestinian Territory 4
Totale 5.130
Città #
Ashburn 457
Fairfield 327
Singapore 251
Hong Kong 213
San Jose 197
Woodbridge 181
Chandler 157
Houston 153
Seattle 133
Cambridge 101
Wilmington 94
Ann Arbor 85
Los Angeles 77
Beijing 59
New York 58
Ho Chi Minh City 48
Council Bluffs 44
Santa Clara 34
Hanoi 32
Dong Ket 28
San Diego 28
Boardman 26
São Paulo 25
Cotonou 24
Tokyo 22
Lauterbourg 21
Padova 21
Princeton 21
Chicago 20
Helsinki 20
Dallas 19
Medford 19
Des Moines 14
Orem 14
Washington 13
Frankfurt am Main 12
Munich 12
Nuremberg 12
Roxbury 12
Rome 11
Da Nang 10
Milan 10
Warsaw 10
Baghdad 9
Montreal 9
Nairobi 9
Phoenix 9
Ulan Bator 9
Bytom 8
London 8
Tripoli 8
Amman 7
Buffalo 7
Chennai 7
Dakar 7
Falls Church 7
Johannesburg 7
Kingston 7
Salt Lake City 7
Tashkent 7
Abidjan 6
Bridgetown 6
Denver 6
Düsseldorf 6
Istanbul 6
Lahore 6
Lusaka 6
Naples 6
Nouakchott 6
Podgorica 6
Seoul 6
Tunis 6
Zagreb 6
Asunción 5
Atlanta 5
Baku 5
Brooklyn 5
Chisinau 5
Guangzhou 5
Harare 5
Havana 5
Managua 5
Nanjing 5
San Francisco 5
Stockholm 5
Toronto 5
Yerevan 5
Amsterdam 4
Antakya 4
Bangkok 4
Bishkek 4
Biên Hòa 4
Campinas 4
Columbus 4
Dar es Salaam 4
Douala 4
Dublin 4
Hefei 4
Jeddah 4
Kuala Lumpur 4
Totale 3.457
Nome #
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors 356
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) 332
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial 331
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 315
The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series 304
Indeterminate Pulmonary Nodules at Diagnosis in Rhabdomyosarcoma: Are They Clinically Significant? A Report From the European Paediatric Soft Tissue Sarcoma Study Group 298
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer 295
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols 270
Pediatric patients with cutaneous melanoma: A European study 263
Paratesticular rhabdomyosarcoma—Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG) 263
Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials 259
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study 252
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) 241
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 232
Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group 231
Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005) 229
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience 229
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups 221
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups 214
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 180
Totale 5.315
Categoria #
all - tutte 14.482
article - articoli 14.482
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 0 0 21 42 10 11 43 16 7 15 56
2022/2023262 47 47 6 40 34 28 1 7 27 4 15 6
2023/2024271 8 34 39 12 31 64 23 34 6 0 12 8
2024/2025559 3 39 27 16 75 9 17 26 66 33 89 159
2025/20262.415 140 143 223 391 212 108 469 171 218 130 118 92
2026/2027329 86 100 83 60 0 0 0 0 0 0 0 0
Totale 5.315